menu
    • menu

    Company profile for VistaGen Therapeutics

    NEW Drugs in Dev: 7
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VistaGen Therapeutics, Inc. (NASDAQ: VTGN), is a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with high unmet need, including major depressive disorder, neuropathic pain social anxiety disorder and suicidal ideation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VistaGen TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    343 Allerton Avenue South San Francisco, CA 94080
    Telephone
    Telephone
    (650) 577-3600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vistagen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vistagen's Social Anxiety Disorder Asset Stumbles In Phase 3
    Vistagen's Social Anxiety Disorder Asset Stumbles In Phase 3

    18 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217824138/en/Vistagen-Announces-Topline-Results-from-PALISADE-3-Phase-3-Public-Speaking-Challenge-Study-of-Fasedienol-for-the-Acute-Treatment-of-Social-Anxiety-Disorder

    BUSINESSWIRE
    18 Dec 2025
    Share Share
    Vistagen To Present At The Menopause Society 2025 Annual Meeting
    Vistagen To Present At The Menopause Society 2025 Annual Meeting

    16 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-16/vistagen-to-present-at-the-menopause-society-2025-annual-meeting

    PHARMIWEB
    16 Oct 2025
    Share Share
    Vistagen to Speak at TD Cowen Neuropsychiatry & Epilepsy Summit
    Vistagen to Speak at TD Cowen Neuropsychiatry & Epilepsy Summit

    09 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250909384975/en/Vistagen-to-Present-at-the-TD-Cowen-5th-Annual-Novel-Mechanisms-in-Neuropsychiatry-Epilepsy-Summit

    BUSINESSWIRE
    09 Sep 2025
    Share Share
    Vistagen's Q1 2026 Financial Results and Corporate Released
    Vistagen's Q1 2026 Financial Results and Corporate Released

    07 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250807014578/en/Vistagen-Reports-Fiscal-Year-2026-First-Quarter-Financial-Results-and-Corporate-Update

    BUSINESSWIRE
    07 Aug 2025
    Share Share
    Vistagen Recognized for Culture, Mental Health Focus
    Vistagen Recognized for Culture, Mental Health Focus

    15 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250715115187/en/Vistagen-Honored-for-Outstanding-Workplace-Culture-and-Mental-Health-Leadership

    BUSINESSWIRE
    15 Jul 2025
    Share Share
    Vistagen names Elissa Cote Chief Corporate Development Officer
    Vistagen names Elissa Cote Chief Corporate Development Officer

    25 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250625610999/en/Vistagen-Appoints-Elissa-Cote-as-Chief-Corporate-Development-Officer

    BUSINESSWIRE
    25 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search